Digital workload in oncology trials: A comparative analysis of e-portal usage and operational insights from a single-center experience
The digitalization of clinical research has increased reliance on electronic portals (e-portals), with significant implications for trial site operations. Our aim is to map the types and number of e-portals required for clinical trials on solid tumors conducted at the Niguarda Cancer Center.
We performed an aggregated analysis of 65 interventional drug trials (phase I–III) initiated between August 2022 and March 2025. For each study, the number and type of e-portals required at the site were recorded and stratified by sponsor type. Analyses were conducted using R.